CPC: Your reliable one-stop peptide service provider
Custom Peptides Catalog Peptides cGMP NCE Peptides Generic Peptide APIs
The first US FDA inspected GMP peptide facility in Asia
Proven track record of 11 years in peptide operation
Global market coverage
From GMP to Non-GMP
Purity from crude to 99%
Quantity from mg to KG
Long sequences peptide up to 220 AAs
Most stringent quality control system
Located in Hangzhou , China , CPC serves scientists and researchers around the world by providing high quality peptides (both GMP and non-GMP grade), technical support and related services. As Chinese first peptide company, CPC has R&D bases both in China and US silicon Valley, holding the business philosophy of “Efficiency, Superiority, and Innovation”. After 12 years’ progress, CPC has become one of the world’s leading peptide service providers.
Initially, CPC started with its patented high-throughput PeptidEx® technology to supply customers with large numbers of individually purified peptides with significant cost savings. This led to the establishment of many other proprietary technologies that currently allows CPC to produce both cGMP and non-GMP peptides (gram to multiple Kg scale).
Focusing on technology, innovation and quality control, CPC was granted an ISO 9001:2008 certification and a full compliance license in cGMP production. Despite so many companies, CPC is among only a handful of companies in the world that can claim both ISO Certification and cGMP licensing. In February 2012, we became the first peptide company to successfully pass US FDA inspection outside of US and Europe regions. High standards and compliance, to which CPC faithfully adheres, allow our customers to have the utmost confidence in the validity of their project.
CPC currently has a state of the art, 143,600 sq ft production campus with >150 full time employees. CPC has produced thousands of peptides ranging in quantity from milligrams to multiple kilograms with purities up to >99%. CPC possesses the ability to perform almost every available peptide modification with the exception of radio labeling.
In July 2012, CPC started the development of a new 163,300 sq ft facility to house phase 3 clinical projects. Through this expansion, CPC is able to establish itself as a world leader in the peptide therapeutic market and will be able to provide our customers with a complete solution to their peptide needs from research quantities to commercial scale.
CPC is currently the preferred vendor for many of the world's top Pharmaceutical and Biotech companies and many Universities. We strive to be not only the best peptide provider in China, but the best around the world.
